Drugs / Astra Zeneca COVID19 vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05028257 | Sep 2021 → May 2023 | anaphylaxis | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Astra Zeneca COVID19 vaccine | “Astra Zeneca COVID19 vaccine” NCT05028257 ↗ |